52 studies found for:    allergy | Closed Studies | Studies With Results | Switzerland | France
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists
Condition: Allergic Asthma
Interventions: Drug: omalizumab at a dose of 0.016mg/kg/IU/mL;   Drug: Placebo
2 Completed
Has Results
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
Condition: HIV Infections
Intervention: Drug: Recombinant interleukin-2 (rIL-2)
3 Completed
Has Results
EASSI - Evaluation of the Safety of Self-Administration With Icatibant
Condition: Hereditary Angioedema
Intervention: Drug: Icatibant
4 Completed
Has Results
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
Conditions: Prostatic Neoplasms;   Neoplasm Metastasis
Interventions: Drug: Aflibercept;   Drug: Placebo (for aflibercept);   Drug: Docetaxel;   Drug: Prednisone or Prednisolone
5 Completed
Has Results
Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma
Condition: Asthma
Intervention: Drug: BI 1744 CL
6 Completed
Has Results
Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: Macugen
7 Completed
Has Results
Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Biological: Adalimumab
8 Completed
Has Results
Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma
Condition: Asthma
Interventions: Drug: Omalizumab;   Drug: placebo
9 Completed
Has Results
Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
Condition: Melanoma
Interventions: Drug: Ipilimumab;   Drug: Placebo;   Drug: Dacarbazine
10 Completed
Has Results
Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx
Condition: HIV Infections
Interventions: Drug: Interleukin 2;   Drug: HAART;   Drug: Treatment interruption
11 Completed
Has Results
Methotrexate-Inadequate Response Study
Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: Subcutaneous (SC) Abatacept;   Drug: Intravenous (IV) Abatacept
12 Completed
Has Results
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
Conditions: Cryopyrin-associated Periodic Syndromes:;   Familial Cold Autoinflammatory Syndrome;   Muckle Wells Syndrome;   Neonatal Onset Multisystem Inflammatory Disease
Intervention: Drug: Canakinumab (ACZ885)
13 Completed
Has Results
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: macitentan (ACT-064992);   Drug: placebo
14 Completed
Has Results
Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: AZLI;   Drug: Placebo
15 Completed
Has Results
Islet Transplantation for Type 1 Diabetes
Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Procedure: Islet Transplantation;   Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Daclizumab;   Drug: Sulfamethoxazole;   Drug: Ganciclovir;   Drug: Trimethoprim;   Drug: Pentamidine
16 Completed
Has Results
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: canakinumab;   Drug: placebo
17 Terminated
Has Results
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab;   Drug: Placebo
18 Terminated
Has Results
(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Ambrisentan;   Drug: Placebo
19 Completed
Has Results
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Apixaban;   Drug: Placebo
20 Completed
Has Results
BUILD 3: Bosentan Use in Interstitial Lung Disease
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: placebo;   Drug: Bosentan

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years